Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C G Kallenberg

Showing results (21-30 of 267) with videos related to

Pageof 27
Sort By:
Clinical and Experimental Rheumatology|July 1, 1993
Autoantibodies in vasculitis: current perspectivesC G Kallenberg
European Journal of Clinical Investigation|January 7, 1998
Anti-neutrophil cytoplasmic antibodies and the endothelium many ways to vasculitisC G Kallenberg
VASA. Supplementum|January 1, 1992
Raynaud's phenomenon as an early sign of connective tissue diseasesC G Kallenberg
VASA. Supplementum|January 1, 1987
Raynaud's phenomenon and systemic diseasesC G Kallenberg
Lupus|June 27, 1998
Pathogenesis of vasculitisC G Kallenberg, P Heeringa
The Netherlands Journal of Medicine|April 1, 1990
Solid phase assays for ANCAC G Kallenberg, N Rasmussen
Hepato-Gastroenterology|January 8, 2000
Anti-neutrophil cytoplasm autoantibodies (ANCA) in autoimmune liver diseasesC Roozendaal, C G Kallenberg
Clinical and Experimental Immunology|May 26, 1999
Are anti-neutrophil cytoplasmic antibodies (ANCA) clinically useful in inflammatory bowel disease (IBD)?C Roozendaal, C G Kallenberg
Nederlands Tijdschrift Voor Geneeskunde|April 29, 1998
[Immunology in clinical practice IX. Systemic vasculitis]C G Kallenberg, J W Tervaert
Current Opinion in Nephrology and Hypertension|August 24, 1999
What is new with anti-neutrophil cytoplasmic antibodies: diagnostic, pathogenetic and therapeutic implicationsC G Kallenberg, J W Tervaert
Pageof 27

Showing results (21-30 of 267) with videos related to

Sort By:
Pageof 27
Clinical and Experimental Rheumatology|July 1, 1993
Autoantibodies in vasculitis: current perspectivesC G Kallenberg
European Journal of Clinical Investigation|January 7, 1998
Anti-neutrophil cytoplasmic antibodies and the endothelium many ways to vasculitisC G Kallenberg
VASA. Supplementum|January 1, 1992
Raynaud's phenomenon as an early sign of connective tissue diseasesC G Kallenberg
VASA. Supplementum|January 1, 1987
Raynaud's phenomenon and systemic diseasesC G Kallenberg
Lupus|June 27, 1998
Pathogenesis of vasculitisC G Kallenberg, P Heeringa
The Netherlands Journal of Medicine|April 1, 1990
Solid phase assays for ANCAC G Kallenberg, N Rasmussen
Hepato-Gastroenterology|January 8, 2000
Anti-neutrophil cytoplasm autoantibodies (ANCA) in autoimmune liver diseasesC Roozendaal, C G Kallenberg
Clinical and Experimental Immunology|May 26, 1999
Are anti-neutrophil cytoplasmic antibodies (ANCA) clinically useful in inflammatory bowel disease (IBD)?C Roozendaal, C G Kallenberg
Nederlands Tijdschrift Voor Geneeskunde|April 29, 1998
[Immunology in clinical practice IX. Systemic vasculitis]C G Kallenberg, J W Tervaert
Current Opinion in Nephrology and Hypertension|August 24, 1999
What is new with anti-neutrophil cytoplasmic antibodies: diagnostic, pathogenetic and therapeutic implicationsC G Kallenberg, J W Tervaert
Pageof 27